{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-277877","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2023-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.506381+00:00","generated_at":"2026-06-08T02:39:53.308478+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aligos Therapeutics President and Board member Leonid Beigelman resigns","bullets":["Leonid Beigelman resigned from the Board effective Nov 9, 2023.","Beigelman also resigned as President effective Dec 1, 2023.","Resignation is not related to any disagreement with the Company.","No replacement for President has been announced.","Beigelman's departure removes a key scientific leader from management."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-277877","json":"https://secwatch.observer/filing/0001193125-23-277877.json","markdown":"https://secwatch.observer/filing/0001193125-23-277877.md","text":"https://secwatch.observer/filing/0001193125-23-277877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523277877/0001193125-23-277877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523277877/d850603d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T02:39:53.308478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f9235eaa6","claim":"Leonid Beigelman resigned as President at Aligos Therapeutics, Inc..","evidence_excerpt":"On November 9, 2023, Leonid Beigelman resigned from the Board of Directors (the “Board”) of Aligos Therapeutics, Inc. (the “Company”), effective immediately, and from his position as President of the Company, effective as of December 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523277877/0001193125-23-277877-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"a012a7362f","claim":"Leonid Beigelman resigned as Member of the Board of Directors at Aligos Therapeutics, Inc..","evidence_excerpt":"On November 9, 2023, Leonid Beigelman resigned from the Board of Directors (the “Board”) of Aligos Therapeutics, Inc. (the “Company”), effective immediately, and from his position as President of the Company, effective as of December 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523277877/0001193125-23-277877-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}